Conexeu Sciences Inc. (CNXU)

Conexeu Sciences Inc. is a medical technology company headquartered in Reno, Nevada, that develops collagen-based regenerative tissue scaffolds. The company was founded in 2022.

Its proprietary platform is built around a collagen extracellular matrix scaffold designed to support the body's own tissue regeneration while limiting inflammation and scarring. Its lead product candidate, a collagen gel known as CXU, is being developed for uses in wound care and tissue repair as well as aesthetic applications such as facial rejuvenation and volume restoration in the face and body. The company positions these products as alternatives to conventional dermal fillers and implants, and several applications remain investigational pending regulatory clearance.